QIAGEN IPA

Identifying novel drug targets in paraganglioma

24 views
May 09, 2023
In disease research, understanding the key genes involved and how they interact to drive disease occurrence or severity is extremely valuable. Discovering previously unknown gene-disease relationships helps us gain insights to develop new potential therapies. To this end, we applied machine learning (ML) to our QIAGEN Knowledge Graph (QKG) to predict novel gene-disease associations. A research team at MicroMatrices, who study familial paraganglioma, investigated potential new targets by identifying differentially expressed genes using laser dissection targeted transcriptomics analysis in tumor vs. normal tissue. They compared the changes found in their case study with predicted gene alterations made by our ML process and found potential new drug targets and candidate drugs. Their treatment hypotheses can be tested in a 3D model of paraganglioma using SpheroMatrices microtissue array (microTMA) technology.

If you'd like to explore a new way to identify potential new drug targets, you won't want to miss this unique opportunity to learn from industry experts about:

How ML used known relationships in the QKG to infer hidden relationships between potential targets and diseases
A library of 1500 disease networks available in QIAGEN Ingenuity Pathway Analysis (IPA)
MicroMatrices' research into paraganglioma and evaluation of novel gene associations predicted by our disease network
Opportunities to verify new drug targets for paraganglioma as well as potential targets in other diseases

Related videos

QIAGEN IPA

Pathway and network analysis on different types of lists with QIAGEN Ingenuity Pathway Analysis...

35 views May 22, 2023

You may not have a typical transcriptomics dataset (i.e., a list of genes...

QIAGEN IPA

Transcriptional response to animal feed supplemented with plant-based antimicrobials

20 views May 09, 2023

In recent years there has been a rapid trend to end use of antibiotic growth...

QIAGEN IPA

QIAGEN Ingenuity Pathway Analysis (IPA) for grant writing and publications with new features

55 views May 02, 2023

QIAGEN Ingenuity Pathway Analysis (IPA) represents a robust resource to aid...

QIAGEN IPA

Proteomics and phosphoproteomics data interpretation using QIAGEN Ingenuity Pathway Analysis

83 views May 02, 2023

In this QIAGEN IPA training, we’ll focus on interpreting proteomics and...